Plasmonix, Inc. — Form D

Plasmonix, Inc. of GAITHERSBURG, MD, a company, filed a Form D exempt-offering notice with the SEC on 2013-07-03. The offering totals $550K, of which $300K was reported sold. Industry: Biotechnology.

Offering

Filed: 2013-07-03
Form: D
Accession: 0001521534-13-000001
Industry: Biotechnology
Exemptions: 06
Total offering: $550K
Amount sold: $300K
Remaining: $250K
Investors: 1
Date of first sale: 2013-04-15
Security types: equity
Revenue range: Decline to Disclose
SEC file number: 021-199034

Issuer

Name: Plasmonix, Inc.
CIK: 0001521534
Entity type: Corporation
Jurisdiction: MARYLAND
Incorporated: 2009
Address: 9119 GAITHER ROAD, GAITHERSBURG, MD, 20877
Phone: 410-625-5939

Officers, directors & promoters (14)

Name	Role	Location
John W Holaday	Director	ROCKVILLE, MD
John W Holaday	Executive Officer	ROCKVILLE, MD
Steven W Meltzer	Director	Gaithersburg, MD
Edward M Rudnic, PhD	Director	Gaithersburg, MD
Jesse Baumgold, PhD	Director	Bethesda, MD
Jesse Baumgold, PhD	Executive Officer	Bethesda, MD
David W Manyak	Director	Gaithersburg, MD
William M Gust, II	Director	Baltimore, MD
William M Gust, II	Executive Officer	Baltimore, MD
Jesse W Baumgold, PhD	Director	Bethesda, MD
Sean M Higgins, PhD	Executive Officer	Baltimore, MD
Jesse E Baumgold, PhD	Director	Bethesda, MD
James E Russo	Executive Officer	Baltimore, MD
Christopher D Geddes	Executive Officer	Baltimore, MD

Other filings by this issuer (5)

Filed	Form	Offering	Sold
2015-07-07	D/A	$565K	$544K
2014-06-13	D	$565K	$315K
2013-11-13	D	$500K	$231K
2012-06-07	D	$500K	$298K
2011-06-21	D	$2.0M	$1.2M

More